Your browser doesn't support javascript.
loading
Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals.
Tamminga, Saskia; van Schendel, Rachèl V; Rommers, Wieke; Bilardo, Caterina M; Pajkrt, Eva; Dondorp, Wybo J; van Maarle, Merel; Cornel, Martina C; Henneman, Lidewij.
Afiliação
  • Tamminga S; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
  • van Schendel RV; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
  • Rommers W; EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands.
  • Bilardo CM; Department of Fetal Medicine and Prenatal Diagnosis, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Pajkrt E; Department of Fetal Medicine and Prenatal Diagnosis, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Dondorp WJ; Department of Obstetrics and Gynecology, Fetal Medicine Unit, Academic Medical Center, Amsterdam, the Netherlands.
  • van Maarle M; Department of Health, Ethics and Society, Faculty of Health, Medicine and Life Sciences, Research Institutes GROW and CAPHRI, Maastricht University, Maastricht, the Netherlands.
  • Cornel MC; Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.
  • Henneman L; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Prenat Diagn ; 35(13): 1316-23, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26411372
OBJECTIVE: The aim of this study was to investigate health professionals' opinions toward offering noninvasive prenatal testing (NIPT) as first-tier screening test regardless of pregnant women's risk, and toward a potential broader range of disorders. METHODS: A questionnaire completed by obstetric health professionals (n = 240) after an in-service NIPT training in the West and North of the Netherlands. RESULTS: The majority (72%) of respondents favored replacing first-trimester combined test (FCT) by NIPT, although 43% preferred to maintain nuchal translucency measurement. Many respondents believed that replacing FCT by NIPT would only have advantages (57%), would lead to more pregnant women opting for prenatal testing (69%), and would simplify counseling (47%). Differences in attitudes toward counseling between health professionals were observed. When considering NIPT to screen for broader range of disorders, the majority (92%) thought that this should include disorders characterized by neonatal death, whereas 52% of the respondents favored testing for fetomaternal risk factors. Overall, 46% thought screening should be offered as a fixed list of disorders. CONCLUSION: Most health professionals favor NIPT instead of FCT but prefer to maintain nuchal translucency measurement. If NIPT becomes available as a first-tier screening test, attention remains necessary to ensure that pregnant women make well-informed decisions in line with the aim of prenatal screening.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diagnóstico Pré-Natal Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Prenat Diagn Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diagnóstico Pré-Natal Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Prenat Diagn Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda